Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis The budget impact of new medicines Leela Barham Budget Impact Test, Drug funding, HTA, market access, NHS, NHSE, NICE, PPRS, Technology Appraisal 0 Comment What could be the impact of proposed new ‘budget impact threshold’ for drugs? Share X The budget impact of new medicines https://pharmaphorum.com/views-and-analysis/budget-impact-new-medicines/
Articles/ Pharma Market Access/ UK & Europe/ Views and analysis NICE plans to charge for appraisals – but pharma wants reform first Leela Barham ABPI, drug prices, market access, NICE, pharma, TA, Technology Appraisal 0 Comment Will NICE introduce fees for pharma companies’ TAs from next year? Share X NICE plans to charge for appraisals – but pharma wants reform first https://pharmaphorum.com/views-and-analysis/nice-proposes-charging-appraisals-pharma-wants-reform-first/
Articles/ Pharma Market Access/ UK & Europe/ Views and analysis Should industry pay for NICE Technology Appraisals? Leela Barham Leela Barham, NHS, NICE, Technology Appraisal 0 Comment NICE needs to plug a gap in its funding Share X Should industry pay for NICE Technology Appraisals? https://pharmaphorum.com/articles/should-industry-pay-for-nice-technology-appraisals/